Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Relugolix

No authors listed
In: Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006.
.
Free Books & Documents
Review

Relugolix

No authors listed.
Free Books & Documents

Excerpt

No information is available on the clinical use of relugolix during breastfeeding. However, amounts in breastmilk appear to be low and would not be expected to cause any adverse effects in breastfed infants. If a mother requires relugolix, it is not a reason to discontinue breastfeeding, but until more data are available, it should only be used with careful infant monitoring during breastfeeding.

PubMed Disclaimer

References

    1. Brimhall DB, Chen YL, Lee S, et al. Transfer of the oral gonadotropin-releasing hormone receptor antagonist relugolix into breast milk of healthy lactating women. Pharmacol Res Perspect 2025;13:e70067. - PMC - PubMed

LinkOut - more resources